Laserfiche WebLink
to obtain drug and alcohol testing records (including positives and refusals <br />to test) from each previous employer (including, whether or not hired, <br />every employer to whom the employee applied to perform any duty <br />designated as a safety -sensitive function by a DOT agency regulation) <br />during the previous 3 years [(See 49 CFR 391.23 (e)]; <br />iii. Likewise, the Company is required to provide such information about test <br />results to potential employers when authorized by the employee in writing, <br />or to others (e.g., in connection with legal proceedings) when required or <br />permitted by Federal or State law. (See 40.25, 40.323-331) <br />iv. The MRO must report drug test results and medical information obtained <br />during the verification process to third parties (e.g., the employer, medical <br />examiner, SAP, DOT agency, or NTSB) under various circumstances <br />without the employee's consent if the MRO determines (in his/her <br />reasonable medical judgment), that: <br />(a) The information is likely to result in a determination that the employee <br />is medically unqualified under an applicable DOT agency regulation; or <br />(b) The information indicates that continued performance by the employee <br />of his or her safety -sensitive function is likely to pose a significant <br />safety risk. (See 49 CFR 40.327 for additional information.) <br />v. In accordance with DOT regulations, the Company and its service <br />agents will provide access to facilities, property, and records to DOT <br />agency representatives; and, in accordance with 49 CFR 40.323, may <br />release an employee's confidential information to officials involved in any <br />action that arises by or on behalf of the employee (e.g., unemployment, <br />worker's compensation hearings, etc.) without the employee's consent. <br />However, the Company or service agent (e.g., MRO) must immediately <br />notify the employee in writing of any such release of information. <br />vi. MROs will be required to report verified positive, adulterated, and <br />substituted controlled substances test results along with any refusal to test determinations to <br />the National Clearinghouse [Ref 382.705 (a) (i, ii)] <br />B-7 REQUIREMENT TO SUBMIT TO TESTING <br />Employees are required to submit to all drug and/or alcohol testing required by DOT regulations <br />or by this Company policy and must appear for such testing within a reasonable time (as determined <br />by the Company), after being directed to do so by the Company. [See 40.61(a), 40.191(a) and Appx <br />B def: "Immediately'] <br />B-8 REFUSAL TO SUBMIT TO TESTING <br />[See 40.25, .191, .261, 285, 382.213 and 382.107 definition of refuse to submit] <br />General. In addition to consequences imposed by DOT agency regulations, <br />an employee's Refusal to submit to testing at the direction of the Company <br />or law enforcement personnel will subject the employee to disciplinary action <br />up to and Including discharge, solely at the option of the Company. <br />(a) As an employee, you have refused to take a drug or alcohol test if you: <br />(1) Fail to appear for any test (except a pre -employment test) within a <br />reasonable time, consistent with FMCSA regulations as determined <br />by the Company, (or, if an owner -operator, by a C/TPA per 40.61(a)]; <br />(2) Fail to remain at the testing site until the testing process is complete, <br />Provided, That an employee who leaves the testing site before the <br />testing process commences (see 40.63(c)) for a pre -employment test <br />is not deemed to have refused to test; <br />(3) Fail to provide a urine specimen for a drug test or fail to attempt to <br />provide a saliva or breath specimen, as applicable, for a drug or <br />2020 Drug Screens Plus. All Rights Reserved_ (18) FMCSA 20200101 266 <br />